Skip to content
Peregrine
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact

News

Ribon Therapeutics announced a $25M investment from Pfizer

Read More

EndoStream Medical’s Nautilus device for treating patients with brain aneurysm is featured on the cover of the acclaimed INR

Read More

Peregrine Ventures Announces New Investor Consortium Including Bristol Myers Squibb, Becton Dickinson and Company, and Elbit Systems

Read More
Restore Medical, FDA

Restore Medical secured a strategic investment of €2.5M from the European Innovation Council

Read More
Momentis Surgical

Memic announces completion of first patient cases using Hominis® Surgical System

Read More

Cordio Mecidal has completed a successful strategic Series C funding round raising a total of $18M

Read More

Magneto Thrombectomy Solutions announces a successful First-in-Human

Read More

Ribon Therapeutics to present at the 2022 American Association for Cancer Research annual meeting

Read More
Catiheal - Nir Altschuler

CartiHeal is acquired by Bioventus

Read More

Aleph Farms expands to new headquarters in Rehovot, Israel’s “biotech hub”

Read More
Page1 Page2 Page3 Page4 Page5
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact
Linkedin-in
©All rights reserved to Peregrine 2025

site by: 

razgroup-logo